NextCure Inc expected to post a loss of 67 cents a share - Earnings Preview

NextCure

01/11/2021 11:14

* NextCure Inc  NXTC.OQ   NXTC.O  is expected to show no change
in quarterly revenue when it reports results on November 3
(estimated). 
​* Refinitiv's mean analyst estimate for NextCure Inc is for a
loss of 67 cents per share. For the same quarter last year, the
company reported a loss of 59 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for NextCure Inc is
$18​, about 54.3% above​ its last closing price of $8.22. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.62       -0.61      -0.65     Missed  -6.4
 Mar. 31 2021  -0.61       -0.59      -0.60     Missed  -2.1
 Dec. 31 2020  -0.61       -0.60      -0.54     Beat    9.7​
 Sep. 30 2020  -0.56       -0.57      -0.59     Missed  -4.2
 Jun.          -0.51​      -0.50      -0.53     Missed  -5.8​
 30​ 2020​                                              
 Mar. 31 2020  -0.44       -0.44      0.33      Beat    174.5​
 Dec. 31 2019  -0.46       -0.45      -0.34     Beat    25.4
 Sep. 30 2019  -0.35       -0.35      -0.37     Missed  -5.7
 This summary was machine generated November 1 at 11:14 GMT.  All
figures in US dollars unless otherwise stated